Tim Watkins insider trades
Open-market stock purchases and sales by Tim Watkins, CMO & Head of Development at Contineum Therapeutics, Inc, from SEC Form 4 filings since Apr 28, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc | Sold | $174K |
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc | Bought (not open market) | $48.7K |
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc | Bought (not open market) | — |
| Mar 2, 2026 | CTNM Contineum Therapeutics, Inc | Sold | $54.2K |
| Mar 2, 2026 | CTNM Contineum Therapeutics, Inc | Bought (not open market) | — |
| Jan 30, 2026 | CTNM Contineum Therapeutics, Inc | Bought (not open market) | — |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc | Sold | $39.4K |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc | Sold | $11.7K |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc | Bought (not open market) | — |
| Dec 29, 2025 | CTNM Contineum Therapeutics, Inc | Sold | $43.6K |
| Dec 29, 2025 | CTNM Contineum Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- CTNM Contineum Therapeutics, Inc: 5 sales, last Jun 30, 2026